MicroPort NeuroScientific Corporation (HKG:2172)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Surgical & Medical Equipment	790.48M	761.76M	665.62M	547.35M	382.80M
Surgical & Medical Equipment Growth	3.77%	14.44%	21.61%	42.99%	72.49%
Total	790.48M	761.76M	665.62M	547.35M	382.80M
Total Growth	3.77%	14.44%	21.61%	42.99%	72.49%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
The PRC	685.55M	686.47M	633.93M	525.44M	382.19M
The PRC Growth	-0.13%	8.29%	20.65%	37.48%	72.22%
outside The PRC	104.93M	75.29M	31.69M	21.91M	610.00K
outside The PRC Growth	39.36%	137.57%	44.65%	3491.80%	-
Total	790.48M	761.76M	665.62M	547.35M	382.80M
Total Growth	3.77%	14.44%	21.61%	42.99%	72.49%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 11, 2026

Data Sources Report a data error